Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jul;50(1):31–34. doi: 10.1038/bjc.1984.136

Oral contraceptive use and the risk of epithelial ovarian cancer.

C La Vecchia, S Franceschi, A Decarli
PMCID: PMC1976937  PMID: 6743513

Abstract

The relation between the use of combination oral contraceptives (OCs) and the risk of epithelial ovarian cancer was investigated in a case-control study conducted in Milan on 209 women below the age of 60 with histologically confirmed epithelial ovarian cancer, and 418 age-matched controls with a spectrum of acute conditions apparently unrelated to OC use. Combination oral contraceptives were used by 18 (9%) cases, and 59 (14%) controls, giving a relative risk estimate of 0.6 (95% confidence interval = 0.3-1.0, P less than 0.05). The risk of ovarian cancer decreased with increasing duration of use and the point estimate remained below unity long after cessation of use. These results were not accounted for by parity, infertility, or other identified potential confounding factors. Thus, the findings of the present study add further support to the evidence emerging from American data of a reduction of approximately 40% in the risk of epithelial ovarian cancer among women who had used oral contraceptives.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annegers J. F., Strom H., Decker D. G., Dockerty M. B., O'Fallon W. M. Ovarian cancer: incidence and case-control study. Cancer. 1979 Feb;43(2):723–729. doi: 10.1002/1097-0142(197902)43:2<723::aid-cncr2820430248>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  2. Casagrande J. T., Pike M. C., Henderson B. E. Oral contraceptives and ovarian cancer. N Engl J Med. 1983 Apr 7;308(14):843–844. doi: 10.1056/NEJM198304073081415. [DOI] [PubMed] [Google Scholar]
  3. Cramer D. W., Hutchison G. B., Welch W. R., Scully R. E., Knapp R. C. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med. 1982 Oct 21;307(17):1047–1051. doi: 10.1056/NEJM198210213071703. [DOI] [PubMed] [Google Scholar]
  4. Franceschi S., La Vecchia C., Helmrich S. P., Mangioni C., Tognoni G. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol. 1982 May;115(5):714–719. doi: 10.1093/oxfordjournals.aje.a113353. [DOI] [PubMed] [Google Scholar]
  5. Hildreth N. G., Kelsey J. L., LiVolsi V. A., Fischer D. B., Holford T. R., Mostow E. D., Schwartz P. E., White C. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 1981 Sep;114(3):398–405. doi: 10.1093/oxfordjournals.aje.a113207. [DOI] [PubMed] [Google Scholar]
  6. La Vecchia C., Franceschi S., Gallus G., Decarli A., Liberati A., Tognoni G. Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol. 1983 Jun;12(2):161–164. doi: 10.1093/ije/12.2.161. [DOI] [PubMed] [Google Scholar]
  7. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  8. McGowan L., Parent L., Lednar W., Norris H. J. The woman at risk for developing ovarian cancer. Gynecol Oncol. 1979 Jun;7(3):325–344. doi: 10.1016/0090-8258(79)90111-2. [DOI] [PubMed] [Google Scholar]
  9. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  10. Newhouse M. L., Pearson R. M., Fullerton J. M., Boesen E. A., Shannon H. S. A case control study of carcinoma of the ovary. Br J Prev Soc Med. 1977 Sep;31(3):148–153. doi: 10.1136/jech.31.3.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rosenberg L., Shapiro S., Slone D., Kaufman D. W., Helmrich S. P., Miettinen O. S., Stolley P. D., Rosenshein N. B., Schottenfeld D., Engle R. L., Jr Epithelial ovarian cancer and combination oral contraceptives. JAMA. 1982 Jun 18;247(23):3210–3212. [PubMed] [Google Scholar]
  12. Simon W. E., Albrecht M., Hänsel M., Dietel M., Hölzel F. Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst. 1983 May;70(5):839–845. [PubMed] [Google Scholar]
  13. Weiss N. S., Lyon J. L., Liff J. M., Vollmer W. M., Daling J. R. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer. 1981 Dec;28(6):669–671. doi: 10.1002/ijc.2910280602. [DOI] [PubMed] [Google Scholar]
  14. Willett W. C., Bain C., Hennekens C. H., Rosner B., Speizer F. E. Oral contraceptives and risk of ovarian cancer. Cancer. 1981 Oct 1;48(7):1684–1687. doi: 10.1002/1097-0142(19811001)48:7<1684::aid-cncr2820480735>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES